Mitochondrial DNA defects: A widening clinical spectrum of disorders

被引:33
|
作者
Sherratt, EJ [1 ]
Thomas, AW [1 ]
Alcolado, JC [1 ]
机构
[1] UNIV WALES COLL MED,DEPT MED,CARDIFF CF4 4XW,S GLAM,WALES
关键词
diabetes; genetics; mitochondria; mitochondrial DNA;
D O I
10.1042/cs0920225
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
1. Mitochondrial DNA has a number of interesting properties including maternal transmission, the ability to replicate in post-mitotic cells, a high mutation rate and an extremely compact molecular architecture with no introns and no large non-coding sequences. 2. Point mutations, deletions and duplications of mitochondrial DNA may occur, Mitochondrial DNA defects may co-exist with wild-type sequence within a cell (heteroplasmy). The level of heteroplasmy may vary in different tissues within the same individual (segregative replication). 3. A number of neurological disorders are characterized by morphological and biochemical mitochondrial defects, It is now clear that mitochondrial DNA mutations underlie these conditions although there is not always a clear correlation between a particular mutation and clinical presentation. 4. Mitochondrial DNA defects, particularly deletions, accumulate in senescent tissue and studies have been performed,vith the aim of linking such somatic mutations with degenerative disorders. 5. Recently mitochondrial DNA mutations have been implicated in a wider range of clinical disorders including diabetes and nerve deafness. 6. Nuclear gene defects may result in mitochondrial disorders by predisposing to multiple mitochondrial DNA deletions or quantitative depletions of mitochondrial DNA content.
引用
收藏
页码:225 / 235
页数:11
相关论文
共 50 条
  • [41] The expanding clinical and pathologic spectrum of mitochondrial DNA polymerase gamma mutations
    Farrell, Michael A.
    Howley, Rachel
    Alderazi, Yazan
    Brett, Francesca
    Moroney, Joan
    Raymond, Murphy
    FASEB JOURNAL, 2007, 21 (05): : A76 - A76
  • [42] Mitochondrial DNA polymerase γ mutations: an ever expanding molecular and clinical spectrum
    Tang, Sha
    Wang, Jing
    Lee, Ni-Chung
    Milone, Margherita
    Halberg, Michelle C.
    Schmitt, Eric S.
    Craigen, William J.
    Zhang, Wei
    Wong, Lee-Jun C.
    JOURNAL OF MEDICAL GENETICS, 2011, 48 (10) : 669 - 681
  • [43] The clinical diagnosis of POLG disease and other mitochondrial DNA depletion disorders
    Cohen, Bruce H.
    Naviaux, Robert K.
    METHODS, 2010, 51 (04) : 364 - 373
  • [44] The neuropathology of mitochondrial DNA disorders
    Betts, J
    Jaros, E
    Perry, R
    Schaefer, A
    Barron, M
    Cottrell, D
    Borthwick, G
    Lightowlers, R
    Turnbull, D
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2004, 1657 : 79 - 79
  • [45] MITOCHONDRIAL MYOPATHIES - CLINICAL DEFECTS
    MORGANHUGHES, JA
    COOPER, JM
    HOLT, IJ
    HARDING, AE
    SCHAPIRA, AHV
    CLARK, JB
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1990, 18 (04) : 523 - 526
  • [46] Autistic spectrum disorders and mitochondrial encephalopathies
    Holtzman, David
    ACTA PAEDIATRICA, 2008, 97 (07) : 859 - 860
  • [47] Mitochondrial DNA mutagenesis in mitochondrial diseases due to defects in DNA Polymerase Gamma
    Copeland, W. C.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2008, 49 (07) : 521 - 521
  • [48] Mitochondrial disorders due to defects in nuclear genes
    Zeviani, Massimo
    NEUROMUSCULAR DISORDERS, 2006, 16 : S54 - S54
  • [49] Defects of mitochondrial β-oxidation:: a growing group of disorders
    Vockley, J
    Whiteman, DAH
    NEUROMUSCULAR DISORDERS, 2002, 12 (03) : 235 - 246
  • [50] CLINICAL SPECTRUM OF MITOCHONDRIAL-DNA MUTATION AT BASE PAIR-8344
    BERKOVIC, SF
    SHOUBRIDGE, EA
    ANDERMANN, F
    ANDERMANN, E
    CARPENTER, S
    KARPATI, G
    LANCET, 1991, 338 (8764): : 457 - 457